FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection.
FluoretiQ has raised €1.3M across 1 funding round from 4 investors, most recently a Seed round in Feb 2022. Based in Bristol, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-02-23 | Seed | €1.3M |
| Deepbridge Capital,MAINStream,OION - Oxford Investment Opportunity Network,SAIC |
| View deal → |
